News & Updates

Patients with major depressive disorder (MDD) generally achieve satisfactory treatment response with antipsychotic treatment, used either as monotherapy or adjunctively, a meta-analysis has shown. However, this benefit comes with an increased risk of adverse events.

Institutions differ considerably in their parental benefits and policies among cardiovascular training programs internationally, which underscores disparities in real-world experiences, reveals a study.

A multicomponent intervention that involves physical activity with technological support and nutritional counseling effectively reduces the incidence of mobility disability in older adults with physical frailty and sarcopenia and short physical performance battery (SPPB) scores of 3‒7, a study has shown.

Cases of the rare monkeypox viral disease have been detected in at least 12 countries and experts are cautiously concerned about yet another health disaster.

Takotsubo syndrome (TTS) in male patients exhibit a distinct high-risk phenotype that needs close in-hospital monitoring and long-term follow-up, according to a study.

The risk of cardiovascular events, such as heart failure (HF) and myocardial infarction (MI), are comparable across different sodium-glucose cotransporter 2 (SGLT2) inhibitors, according to a recent real-world Japan study.

Around 75 percent of patients on clozapine develop treatment-induced gastrointestinal hypomotility (CIGH), which contributes to substantial risks of serious morbidity and mortality, a study reports.

In the treatment of urinary incontinence, urotherapy appears to be effective in children with cerebral palsy, helping reduce symptoms although at a slower rate compared with their typically developing counterparts, according to a study.